PHUSE will bring together the clinical data science community for a week of innovation, collaboration and fresh perspectives. With interactive discussions and hands-on learning, this event is all about sparking ideas and pushing boundaries.
Asia’s clinical trial landscape presents a regulatory "Rubik’s Cube," where missing a single registration deadline or misinterpreting voluntary versus mandatory requirements can lead to enforcement actions, including daily fines or rejection of marketing applications. As the fastest-growing region for clinical trial activity, Asia requires an understanding of 21 distinct disclosure frameworks, with unique platforms, timelines and consequences that even experienced sponsors often underestimate.
Participants will gain actionable strategies for developing jurisdiction-specific compliance frameworks, managing multi-registry coordination, and transforming disclosure obligations from compliance burdens into competitive advantages that strengthen stakeholder trust and regulatory readiness.
Clinical trial registration data has become more patient-friendly in recent years: plain language descriptions, clearer study populations, accessible terminology. These changes help patients understand what is being studied. But the pendulum may have swung too far. As plain language practices expand across registration fields, are we losing the clinical specificity physicians rely on to identify trials for their patients? Early insights from our ongoing research suggest there may be an unintended trade-off. Strategies designed to protect competitive information or simplify trial listings for patients can also reduce the precision physicians need to make confident referrals.
This session will explore how current registration practices influence physician trial discovery and referral behaviour. Rather than calling for dramatic overhauls, the discussion will highlight practical ways sponsors can review their registration data with both audiences in mind, ensuring accessibility for patients while maintaining the clinical clarity physicians require.
Ben Evans
Disclosure Regulations Research Manager, Citeline
Ben Evans leads the development and evolution of TrialScope Intelligence, a global clinical trial regulatory intelligence platform that delivers high-quality, actionable content to help clients navigate complex disclosure regulations. His role combines research, strategy, and cross-functional collaboration, working closely with regulatory experts, product, tech, and commercial teams to ensure alignment with client needs and company goals.
Francine Lane
VP of Global Transparency, Citeline
Francine Lane is Senior Director of Product at Citeline and former chair of the Drug Information Association (DIA) Clinical Trial Disclosure Community. Francine is responsible for helping TrialScope Disclose and TrialSummaries.com customers meet and exceed current disclosure expectations globally, giving them the tools they need to satisfy the requirements in this evolving industry. Francine also dedicates her time building relationships with external stakeholders — including sponsors, investigators, regulators, and transparency and patient advocates — to help align the goals and expectations of these groups, as well as help identify more consistent ways sponsors can meet transparency expectation and requirements.